Cite
Demaret J, Lefèvre G, Vuotto F, et al. Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020;9(12):e1217doi: 10.1002/cti2.1217.
Demaret, J., Lefèvre, G., Vuotto, F., Trauet, J., Duhamel, A., Labreuche, J., Varlet, P., Dendooven, A., Stabler, S., Gachet, B., Bauer, J., Prevost, B., Bocket, L., Alidjinou, E. K., Lambert, M., Yelnik, C., Meresse, B., Dubuquoy, L., Launay, D., Dubucquoi, S., Montaigne, D., Woitrain, E., Maggiotto, F., Bou Saleh, M., Top, I., Elsermans, V., Jeanpierre, E., Dupont, A., Susen, S., Brousseau, T., Poissy, J., Faure, K., Labalette, M. (2020). Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clinical & translational immunology, 9(12), e1217. https://doi.org/10.1002/cti2.1217
Demaret, Julie, et al. "Severe SARS-CoV-2 patients develop a higher specific T-cell response." Clinical & translational immunology vol. 9,12 (2020): e1217. doi: https://doi.org/10.1002/cti2.1217
Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M. Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020 Dec 23;9(12):e1217. doi: 10.1002/cti2.1217. eCollection 2020. PMID: 33376594; PMCID: PMC7757425.
Copy
Download .nbib